These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 37301432)
1. A Case Study in Health Disparities: Barriers to Immunotherapy for Venom-Induced Anaphylaxis. Satyavarapu I; Hein N; Carlson JC J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2568-2569. PubMed ID: 37301432 [No Abstract] [Full Text] [Related]
2. Hymenoptera venom immunotherapy: Past, present, and future. Oppenheimer J; Golden DBK Ann Allergy Asthma Immunol; 2018 Sep; 121(3):276-277. PubMed ID: 29909053 [No Abstract] [Full Text] [Related]
3. Rush Hymenoptera venom immunotherapy: successful treatment in a patient with systemic mast cell disease. Engler RJ; Davis WS J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):556-9. PubMed ID: 8083461 [No Abstract] [Full Text] [Related]
4. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. Fricker M; Helbling A; Schwartz L; Müller U J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781 [TBL] [Abstract][Full Text] [Related]
5. [When can desensitization with bee and wasp venom be stopped?]. Oei HD; Stroes ES; Beukema WP; van der Zwan JC Ned Tijdschr Geneeskd; 1991 Apr; 135(16):719-20. PubMed ID: 2038399 [No Abstract] [Full Text] [Related]
6. Ultrarush immunotherapy in patients with Hymenoptera venom allergy. Ruëff F; Przybilla B J Allergy Clin Immunol; 2001 May; 107(5):928-9. PubMed ID: 11344369 [No Abstract] [Full Text] [Related]
7. [Highly purified toxin extracts for desensitization. Insect-sting allergy: a causal treatment is possible]. MMW Munch Med Wochenschr; 1979 Aug; 121(34):1057. PubMed ID: 114755 [No Abstract] [Full Text] [Related]
8. Human albumin causes anaphylaxis during bee venom immunotherapy. Nakonechna A; Abuzakouk M Ann Allergy Asthma Immunol; 2014 Jun; 112(6):559-60. PubMed ID: 24785838 [No Abstract] [Full Text] [Related]
9. Immunotherapy with Vespula venom for Vespa velutina nigrithorax anaphylaxis: Preliminary clinical and immunological results. Rodríguez-Vázquez V; Armisén M; Gómez-Rial J; Lamas-Vázquez B; Vidal C Clin Exp Allergy; 2022 Feb; 52(2):345-347. PubMed ID: 34735733 [No Abstract] [Full Text] [Related]
10. Venom extracts available to treat patients at risk from insect stings. Gunby P JAMA; 1979 May; 241(21):2243-6. PubMed ID: 439282 [No Abstract] [Full Text] [Related]
11. [Immunotherapy against hymenoptera venom: report of ten patients]. Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358 [TBL] [Abstract][Full Text] [Related]
12. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients. Sturm G; Kränke B; Rudolph C; Aberer W J Allergy Clin Immunol; 2002 Dec; 110(6):928-33. PubMed ID: 12464961 [TBL] [Abstract][Full Text] [Related]
13. IgG and IgE antibodies after immunotherapy with bee and wasp venom. Kemeny DM; Lessof MH; Patel S; Youlten LJ; Williams A; Lambourn E Int Arch Allergy Appl Immunol; 1989; 88(1-2):247-9. PubMed ID: 2707888 [TBL] [Abstract][Full Text] [Related]
15. Discontinuation of venom immunotherapy. Golden DB J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):703-4. PubMed ID: 9802387 [No Abstract] [Full Text] [Related]
16. [Intolerance of specific immunotherapy with Hymenoptera venom: jumping the hurdle with omalizumab]. Wieczorek D; Kapp A; Wedi B Hautarzt; 2014 Sep; 65(9):791-5. PubMed ID: 25234627 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for hymenoptera venom and biting insect hypersensitivity. Müller UR; Golden DB; Demarco PJ; Lockey RF Clin Allergy Immunol; 2004; 18():541-59. PubMed ID: 15042934 [No Abstract] [Full Text] [Related]
18. [Bee and wasp venom allergy. Clinical aspects, prevention and therapy]. Ring J; Lonsdorf G; Schury W; Burg G MMW Munch Med Wochenschr; 1982 Jun; 124(24):587-90. PubMed ID: 6810134 [No Abstract] [Full Text] [Related]